Weekly Update

McKesson Sees Value Plunge, Ratings Lowered Amid Drug-Price Pushback From Consumers

Pharmaceutical retailer McKesson’s (MCK) stock price plunged and analyst ratings were cut on Friday as the price of branded drugs declined amid pushback from consumers. The San Francisco-based company, which has a market capitalization of about $28 billion, on Thursday lowered its 2017 earnings outlook and reported second-quarter results thatRead More